NSAIDs

Descripción

Introductory Pharmacology Mapa Mental sobre NSAIDs, creado por Daniel Elandix G el 08/10/2013.
Daniel Elandix G
Mapa Mental por Daniel Elandix G, actualizado hace más de 1 año
Daniel Elandix G
Creado por Daniel Elandix G hace alrededor de 11 años
339
1

Resumen del Recurso

NSAIDs

Nota:

  • Non-steroidal anti Inflammatory drugs.
  1. Effects

    Nota:

    •  3 primary effects: Anti-inflammatory effect: Modification of the inflammatory reaction. Analgesic effect: Reduction of pain, Antipyretic effect: Lowering of raised temperatures.
    1. Anti Inflammatory

      Nota:

      • Release of prostaglandins produce increased vasodilation and vascular permeability Inhibition reduces inflammatory reaction.
      1. Anti-pyretic

        Nota:

        • Inhibition of E type prostaglandins in response to IL-1 Prostaglandins E responsible for elevating hypothalamic set point.
        1. Analgesic

          Nota:

          • Decreased prostaglandins, Hence no sensitization of nociceptive nerve endings to other inflammatory mediators such as bradykinin and histamine
        2. Classes of NSAIDs

          Nota:

          • Note that the paracetamol has no anti-inflammatory effect.
          1. Aspirin

            Nota:

            • Acetylsalicyclic acid. Non-selective inhibitor. Irreversibly inhibited COX and inhibit the platelet aggregation. However there are adverse effects such bleeding into the gut (COX1 housekeeping effects lowered). Not given to people under age of 16 due to possible brain inflammation and liver damage.
            1. Iboprofens and non selective NSAIDS

              Nota:

              • Reversible COX inhibitors Treatment for mild to moderate pain and inflammation Side effects include GIT potential renal problems due to retained sodium and potassium.
              1. COX-2 Inhibitor

                Nota:

                • Selectivive, inhibitors have the antipyretic, analgesic and anti-inflammatory. ---Coxibs.
                1. Paracetamol (acetaminophen)
                2. Topical Opthalmic NSAIDS

                  Nota:

                  • Applied in the eye, but may be absorbed in the systemic circulation. Used for treatment of corneal abration, decrease postoperative ocular inflammation or allergic inflammations, photophobia (abnormal sensitivity to light)
                  1. Exercise

                    Nota:

                    • Affect platelet aggregation May induce GIT bleeding Delayed onset of muscle soreness and may enhance performance
                  2. Effect
                    1. Cyclooxygenases
                      1. COX1

                        Nota:

                        • It is for constituitive function. It produces housekeeping functions for stomach, intestines lungs... Such as endothelial integrity, vascular patency, gastric mucosal integrity, bronchodilation Kidney is to maintain renal function Platelets, platelet function. If it was inhibited. it may provide unwanted side effects.
                        1. COX2

                          Nota:

                          • Inducible inflammatory responses Blocking it provides therapeutic anti-inflammatory effects.
                          1. Synthesis

                            Nota:

                            • Phospholipid turns to Arachidonic acid via Phospholipase A2 Then arachidonic acid can branch into 2 paths, One was catalysed by cyclooxygenase to PGG2 and subsequently all the way to Prostaglandins and thromboxanes and prostacyclin The other was catalysed by 5-lipoxygenase into cysteinyl and LTs.
                          2. Inhibition

                            Nota:

                            • Irreversible inhibiton: Aspirin Competitive Inhibition : most NSAIDS Reversible Non-competitive inhibition: Paracetamol.
                          3. Side effects
                            1. Glucocorticoids

                              Nota:

                              • Anti-inflammatory and immunosuppressant Used in certain treatments such as Rhematoid arthritis. inflammatory bowel condition, bronchial asthma, inflammatory skin conditions.
                              1. Anti-inflammatory

                                Nota:

                                • Reduced production of eicosanoids, reduced and inhibit formation of arachidonic acid. It also inhibits phospholiopase A2 and formation of prostaglandins and leukotrienes
                                1. Immunosuppresant

                                  Nota:

                                  • Inhibit accumulation of neutrophils and monocytes Decreased antigen processing by macrophage Decreased T-helper cell function, phagocytosis, antibody production, and decreased production of IL-2
                                  1. Side Effects

                                    Nota:

                                    • Suppression of the immune system  Altered bone metabolism (may lead to osteoporosis) Impaired wound healing Development of diabetes and peptic ulcers. Growth suppression in children like asthma, (minimised side effects by inhalation) Cushing's Syndrome.
                                  2. DMARDS

                                    Nota:

                                    • Combination of drugs.
                                    1. Anti-cytokine

                                      Nota:

                                      • Biological preparations that target action of cytokines such as TNF-alpha. Monoclonal antibodies against the a chain of the IL-2 receptors
                                      1. Anti-histamines

                                        Nota:

                                        • H1 receptor antagonists Uses for allergic reactions Antiemetics for motion sickness Sedation
                                        Mostrar resumen completo Ocultar resumen completo

                                        Similar

                                        AINES
                                        Miguel Pinel
                                        Autonomic Pharmacology
                                        Daniel Elandix G
                                        Drugs of Addiction
                                        Daniel Elandix G
                                        Site of Drug Action: Dose Responses
                                        Daniel Elandix G
                                        Drug Metabolism/Excretion
                                        Daniel Elandix G
                                        Pharmacology of Autocoids
                                        Daniel Elandix G
                                        Pharmacology of Pain
                                        Ayanime Umoh
                                        Agonist and Antagonists
                                        Daniel Elandix G
                                        Adrenergic Mechanisms
                                        Daniel Elandix G
                                        Regulation of Neurotransmitter
                                        Daniel Elandix G
                                        H. Pylori and Peptic Ulcer Disease
                                        Daniel Elandix G